Direxion Daily TSLA Bull 2X Shares, ProShares UltraPro Short QQQ, Exxon Mobil, Chevron, Amgen, PepsiCo, and Merck & Co., Inc. are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that distribute a portion of their earnings to shareholders on a regular basis, typically quarterly or annually. These payments, known as dividends, provide investors with an ongoing income stream in addition to any capital appreciation from the stock’s price growth. Companies that pay dividends are often established, profitable firms with stable cash flows. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
Direxion Daily TSLA Bull 2X Shares (TSLL)
Direxion Daily TSLA Bull 2X Shares stock traded up $2.09 during midday trading on Monday, hitting $14.45. The stock had a trading volume of 324,375,265 shares, compared to its average volume of 112,195,135. Direxion Daily TSLA Bull 2X Shares has a 52-week low of $6.29 and a 52-week high of $41.50. The company has a market capitalization of $7.09 billion, a PE ratio of 88.55 and a beta of -5.14. The firm's fifty day moving average is $11.92 and its two-hundred day moving average is $17.38.
Read Our Latest Research Report on TSLL
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
NASDAQ SQQQ traded down $0.61 during trading on Monday, hitting $22.22. 111,653,011 shares of the stock traded hands, compared to its average volume of 62,569,046. The firm has a 50-day simple moving average of $27.25 and a 200-day simple moving average of $30.59. ProShares UltraPro Short QQQ has a 12-month low of $21.52 and a 12-month high of $57.95.
Read Our Latest Research Report on SQQQ
Exxon Mobil (XOM)
Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.
Shares of XOM traded down $2.96 during midday trading on Monday, hitting $111.74. The stock had a trading volume of 18,226,642 shares, compared to its average volume of 15,656,319. Exxon Mobil has a 1 year low of $97.80 and a 1 year high of $126.34. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.24 and a quick ratio of 0.90. The stock's 50 day moving average is $106.56 and its 200 day moving average is $108.56. The firm has a market cap of $481.57 billion, a PE ratio of 14.83, a price-to-earnings-growth ratio of 2.29 and a beta of 0.49.
Read Our Latest Research Report on XOM
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
NYSE CVX traded down $2.75 during trading on Monday, hitting $146.80. The stock had a trading volume of 7,469,670 shares, compared to its average volume of 8,229,944. Chevron has a one year low of $132.04 and a one year high of $168.96. The stock has a 50 day simple moving average of $139.37 and a 200 day simple moving average of $148.58. The stock has a market capitalization of $256.37 billion, a price-to-earnings ratio of 16.80, a P/E/G ratio of 2.63 and a beta of 0.83. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.82 and a current ratio of 1.08.
Read Our Latest Research Report on CVX
Amgen (AMGN)
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout.
AMGN traded down $14.26 during trading hours on Monday, reaching $275.07. 3,227,581 shares of the company's stock traded hands, compared to its average volume of 2,823,768. The company has a quick ratio of 0.88, a current ratio of 1.17 and a debt-to-equity ratio of 8.70. The firm has a 50-day moving average price of $281.82 and a 200 day moving average price of $286.10. Amgen has a 52-week low of $253.30 and a 52-week high of $346.85. The firm has a market capitalization of $147.91 billion, a PE ratio of 24.97, a PEG ratio of 2.62 and a beta of 0.51.
Read Our Latest Research Report on AMGN
PepsiCo (PEP)
PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
Shares of NASDAQ PEP traded down $0.19 during mid-day trading on Monday, reaching $128.88. The company had a trading volume of 6,254,456 shares, compared to its average volume of 6,790,298. PepsiCo has a 52 week low of $127.75 and a 52 week high of $180.91. The business's 50-day moving average is $133.19 and its 200-day moving average is $143.83. The stock has a market cap of $176.70 billion, a price-to-earnings ratio of 18.94, a price-to-earnings-growth ratio of 3.71 and a beta of 0.45. The company has a current ratio of 0.83, a quick ratio of 0.65 and a debt-to-equity ratio of 2.13.
Read Our Latest Research Report on PEP
Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
Shares of NYSE:MRK traded up $0.82 during trading on Monday, reaching $79.88. 9,008,866 shares of the company were exchanged, compared to its average volume of 13,027,483. The business's fifty day simple moving average is $78.89 and its 200-day simple moving average is $88.32. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.41 and a quick ratio of 1.16. Merck & Co., Inc. has a 12-month low of $73.31 and a 12-month high of $134.63. The firm has a market capitalization of $200.57 billion, a PE ratio of 11.62, a P/E/G ratio of 0.82 and a beta of 0.38.
Read Our Latest Research Report on MRK
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Direxion Daily TSLA Bull 2X Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Direxion Daily TSLA Bull 2X Shares wasn't on the list.
While Direxion Daily TSLA Bull 2X Shares currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
